Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Grieve

Showing results (71-80 of 128) with videos related to

Pageof 13
Sort By:
Journal of the Intensive Care Society|December 6, 2018
Psychological outcomes following a nurse-led preventative psychological intervention for critically ill patients trial: Statistical and health economic analysis planJerome Wulff, Zia Sadique, Richard Grieve, et al.
BMJ Open|May 16, 2025
Variation in acute myocardial infarction management by kidney function across hospitals in England: a cross-sectional study using the Myocardial Ischaemia National Audit Project (MINAP)Patrick Bidulka, Clive Weston, Mark de Belder, et al.
Pharmacoeconomics|March 25, 2022
Target Trial Emulation for Transparent and Robust Estimation of Treatment Effects for Health Technology Assessment Using Real-World Data: Opportunities and ChallengesManuel Gomes, Nick Latimer, Marta Soares, et al.
Statistical Methods in Medical Research|December 19, 2013
Multilevel models for cost-effectiveness analyses that use cluster randomised trial data: An approach to model choiceEdmond S-W Ng, Karla Diaz-Ordaz, Richard Grieve, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|May 2, 2023
Adapting Patient and Public Involvement processes in response to the Covid-19 pandemicClaire Snowdon, Elizabeth Silver, Paul Charlton, et al.
Ophthalmology|December 2, 2009
Verteporfin photodynamic therapy cohort study: report 3: cost effectiveness and lessons for future evaluationsRichard Grieve, Carla Guerriero, Jemma Walker, et al.
The New England Journal of Medicine|January 10, 2014
A randomized trial of hyperglycemic control in pediatric intensive careDuncan Macrae, Richard Grieve, Elizabeth Allen, et al.
Cost Effectiveness and Resource Allocation : C/E|July 25, 2009
Cost-Effectiveness and Resource Allocation (CERA) - directions for the futureRob Baltussen, Arnab Acharya, Kathryn Antioch, et al.
Ophthalmology|December 2, 2009
Verteporfin photodynamic therapy cohort study: report 2: clinical measures of vision and health-related quality of lifeBarnaby C Reeves, Julia Langham, Jemma Walker, et al.
Health Economics|September 26, 2024
Going beyond randomised controlled trials to assess treatment effect heterogeneity across target populationsDavid G Lugo-Palacios, Patrick Bidulka, Stephen O'Neill, et al.
Pageof 13

Showing results (71-80 of 128) with videos related to

Sort By:
Pageof 13
Journal of the Intensive Care Society|December 6, 2018
Psychological outcomes following a nurse-led preventative psychological intervention for critically ill patients trial: Statistical and health economic analysis planJerome Wulff, Zia Sadique, Richard Grieve, et al.
BMJ Open|May 16, 2025
Variation in acute myocardial infarction management by kidney function across hospitals in England: a cross-sectional study using the Myocardial Ischaemia National Audit Project (MINAP)Patrick Bidulka, Clive Weston, Mark de Belder, et al.
Pharmacoeconomics|March 25, 2022
Target Trial Emulation for Transparent and Robust Estimation of Treatment Effects for Health Technology Assessment Using Real-World Data: Opportunities and ChallengesManuel Gomes, Nick Latimer, Marta Soares, et al.
Statistical Methods in Medical Research|December 19, 2013
Multilevel models for cost-effectiveness analyses that use cluster randomised trial data: An approach to model choiceEdmond S-W Ng, Karla Diaz-Ordaz, Richard Grieve, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|May 2, 2023
Adapting Patient and Public Involvement processes in response to the Covid-19 pandemicClaire Snowdon, Elizabeth Silver, Paul Charlton, et al.
Ophthalmology|December 2, 2009
Verteporfin photodynamic therapy cohort study: report 3: cost effectiveness and lessons for future evaluationsRichard Grieve, Carla Guerriero, Jemma Walker, et al.
The New England Journal of Medicine|January 10, 2014
A randomized trial of hyperglycemic control in pediatric intensive careDuncan Macrae, Richard Grieve, Elizabeth Allen, et al.
Cost Effectiveness and Resource Allocation : C/E|July 25, 2009
Cost-Effectiveness and Resource Allocation (CERA) - directions for the futureRob Baltussen, Arnab Acharya, Kathryn Antioch, et al.
Ophthalmology|December 2, 2009
Verteporfin photodynamic therapy cohort study: report 2: clinical measures of vision and health-related quality of lifeBarnaby C Reeves, Julia Langham, Jemma Walker, et al.
Health Economics|September 26, 2024
Going beyond randomised controlled trials to assess treatment effect heterogeneity across target populationsDavid G Lugo-Palacios, Patrick Bidulka, Stephen O'Neill, et al.
Pageof 13